Cyclosporine suppresses rat hepatic cytochrome P450 in a time-dependent manner

Kidney International

Volumn 54, Issue 1, 1998, Pages 216-223

  Brunner, Lane J ^a   Bennett, William M ^b   Koop, Dennis R ^b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b NONE

Author keywords

Cyclosporine nephropathy; Cytochrome; Hepatic isoforms; Immunosuppression; Metabolism; Nephrotoxicity; Pharmacokinetics

Indexed keywords

CYCLOSPORIN; CYTOCHROME P450; FUROSEMIDE;

ANIMAL EXPERIMENT; ARTICLE; CATALYSIS; CHROMATOGRAPHY; CHRONOTHERAPY; DOSE TIME EFFECT RELATION; DRUG EFFECT; ENZYME REPRESSION; IMMUNOBLOTTING; KIDNEY DISEASE; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEROID HYDROXYLATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031860936     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00970.x     Document Type: Article

References (37)

1. BENNETT WM, NORMAN DJ: Action and toxicity of cyclosporine. Annu Rev Med 37:215-224, 1986
2. KAHAN BD: Cyclosporine. N Engl J Med 321:1725-1738, 1989
3. DUELLL E, FISCHER V, FISHER G, ASTROM A, VOORHEES J: Cyclosporine A metabolism by cytochrome P-450III occurs in microsomcs from rat liver but not from normal epidermis or psoriatic lesions. J Invest Dermatol 96:827-931, 1991
4. KRONBACH T, FISCHER V, MEYER UA: Cyclosporine metabolism in human liver: Identification of a cytochrome P450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs, Clin Pharmacol Ther 43:630-635, 1988
5. KAHAN BD, SHAW LM, HOLT D, GREVEL J, JOHNSON A: Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine. Clin Chem 36:1510-1516, 1990
6. MAUER G, LOOSLI HR, SCHREIER E, KELLER B: Disposition of cyclosporin in several animal species and man. 1. Structural elucidations of its metabolites. Drug Metab Dispos 12:120-126, 1984
7. NELSON DR, KAMATAKI T, WAXMAN DJ, GUENGERICH FP, ESTABROOK RE, FEYEREISEN R, GONZALEZ FJ, COON MJ, GUNSALUS IC, GOTOH O, OKUDA K, NEBERT DW: The P450 superfamily: Update on new sequences, gene mapping, assession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12:1-51, 1993
8. BRUNNER LJ, BENNETT WM, KOOP DR: Selective suppression of rat hepatic microsomal activity during chronic cyclosporine nephrotoxicity. J Pharm Exp Ther 277:1710-1718, 1996
9. PRUEKSARITANONT T, CORREIA MA, RETTIE AE, SWINNEY DC, THOMAS PE, BENET LZ: Cyclosporine metabolism by rat liver microsomes: Evidence for involvement of enzyme(s) other than cytochromes P450 3A. Drug Metab Dispos 21:730-737, 1993
10. CUNNINGHAM C, BURKE MD, WHEATLEY DN, THOMSON AW, SIMPSON JG, WHITING PH: Amelioration of cyclosporin-induced nephrotoxicity in rats by induction of hepatic drug metabolism. Biochem Pharmacol 34:573-587, 1985
11. LI G, TREIBER G, MEINHAUSEN J, WOLF J, WERRINGLOER J, KLOTZ U: Is cyclosporin A an inhibitor of drug metabolism. Br J Clin Pharmacol 30:71-77, 1990
12. MAHNKE A, STROTKAMP D, ROOS PH, GANSTEIN WG, CHABOT GG, NEF P: Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Arch Biochem Biophys 337:62-68, 1997
13. BURDMAN EA, ROSEN SR, LINDSLEY J, ELZINGA L, ANDOH T, BENNETT WM: Production of less chronic nephrotoxicity by cyclosporine G than cyclosporine A in a low-salt rat model. Transplantation 55:963-966, 1993
14. LUKE DR, VADIFI K, BRUNNER LJ: Time-dependent pharmacokinetics and toxicity of cyclosporine. Chronobiol Int 5:353-362, 1988
15. 4 (rabbit liver). Methods Enzymol 52:109-117, 1978
16. LAEMMLI UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
17. SCHNIER GG, LAETHEM CL, KOOP DR: Identification and induction of cytochromes P450, P450IIE1 and P450 1A1 in rabbit bone marrow. J Pharmacol Exp Ther 251:790-796, 1989
18. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951
19. 4-steroid 5α-reductase, flavin-containing monooxygenase, and sex-specific cytochromes P-450. J Biol Chem 261:10728-10735, 1986
20. PTACHCINSKI RJ, VENKATARAMANAN R, BURCKART GJ: Clinical pharmacokinetics of cyclosporin. Clin Phanmacokinet 11:107-132, 1986
21. WILMS HWF, STRAETEN V, LISON AE: Different pharmacokinetics of cyclosporine A early and late after renal transplantation. Transplant Proc 20(Suppl 2):481-484, 1988
22. BAILEY DG, ARNOLD MO, SPENCE JD: Grapefruit juice and drugs: How significant is the interaction? Clin Pharmacokinet 26:91-98, 1994
23. FIRST MR, SCHROEDER TJ, ALEXANDER JW, STEPHENS GW, WEISKITTEL P, MYRE SA, PESCE AJ: Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients. Transplantation 51:365-370, 1991
24. HALPERT JR, GUENGERICH FP, BEND JR, CORREIA MA: Contemporary issue in toxicology: Selective inhibitors of cytochromes P450. Toxicol Appl Pharmacol 125:163-175, 1994
25. YEE GC, MCGUIRE TR: Pharmacokinetic drug interactions with cyclosporin (Part I), Clin Pharmacokinet 19:319-332, 1990
26. YEE GC, MCGUIRI TR: Pharmacokinetic drug interactions with cyclosporin (Part II). Clin Pharmacokinet 19:400-415, 1990
27. 2-cyclosporin on hepatic steroid metabolism and endocrine parameters in male Sprague-Dawley rats. J Steroid Biochem Molec Biol 39:33-37, 1991
28. ISOGAI M, SHIMADA N, KAMATAKI T, IMAOKA S, FUNAE Y: Changes in the amounts of cytochromes P450 in rat hepatic microsomes produced by cyclosporin A. Xenobiotica 23:799-807, 1993
29. 5 and by microsomes: Metabolite identification. J Biol Chem 258:11738-11744, 1983
30. RYAN DE, IIDA S, WOOD AW, THOMAS PE, LIEBER CS, LEVIN W: Characterization of three highly purified cytochromes P-450 from hepatic microsomes of adult male rats. J Biol Chem 259:1239-1250, 1984
31. CAPDEVILA JH, WEI S, YAN J, KARARA A, JACOBSON HR, FALCK JR, GUENGERICH FP, DUBOISE RN: Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J Biol Chem 267:21720-21726, 1992
32. DARBAR D, DELL' ORTO S, MORJKE K, WILKINSON GR, RODEN DM: Dietary salt increases first-pass elimination of oral quinidine. Clin Pharmacol Ther 61:292-300, 1997
33. SAITO M, OH-HASHI A, KUBOTA M, NISHIDE E, YAMAGUCHI M: Mixed function oxidases in response to differenct types of dietary lipids in rats. Br J Nutr 63:249-257, 1990
34. Yoo JS, NING SM, PANTUCK CB, YANG CS: Regulation of hepatic microsomal cytochrome P450IIE1 level by dietary lipids and carbohydrates in rats. J Nutr 121:959-965, 1991
35. MORGAN ET, MACGEOCH C, GUSTAFSSON J: Sexual differentiation of cytochrome P-450 in rat liver: Evidence for a constitutive isozyme as the male-specific 16. Mol Pharmacol 27:471-479, 1985
36. WAXMAN DJ, LEBLANC GA, MORRISSEY JJ, STAUNTON J, LAPENSON DP: Adult male-specific and neonatally programmed rat hepatic P-450 forms RLM2 and 2a are not dependent on pulsatile plasma growth hormone for expression. J Biol Chem 463:11396-11406, 1988
37. LUKE DR, BRUNNER LJ, VADIEI K: Bioavailability assessment of cyclosporine in the rat: Influence of route of administration. Drug Metab Dispos 18:158-162, 1990.